Midwest Biomedical Research Foundation
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Midwest Biomedical Research Foundation sits in the top decile of US sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count).
Midwest Biomedical Research Foundation: 13 sponsored US clinical trials, 2 recruiting.
Midwest Biomedical Research Foundation sponsors 13 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 6 completed. 0 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Barrett's Esophagus, with 2 trials.
Top-decile sponsor footprint
Midwest Biomedical Research Foundation ranks in the top decile of sponsors by registered trial count (#1,049 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
6 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (54.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
13 total, page 1 of 1
Barrett's Esophagus Related Neoplasia (BERN) Project
NCT00590239
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
NCT00574327
Three Arm Rand Trial of HD Light vs Reveal® Cap vs Endocuff Cap for Detection of Colorectal Adenomas (TRACE)
NCT03952611
Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy
NCT03167970
Combined Donepezil and Selegiline Effects on Cocaine-Reinforced Behavior
NCT01495195
Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus
NCT01572987
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease
NCT01572974
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
NCT01574573
Diagnosis of Acid Reflux Disease Using Novel Imaging: A Prospective Study
NCT02081404
The Study of Barrett's Esophagus: What Are the Factors of Progression
NCT00586404
Yield and Safety of Colonoscopy in Patients Older Than 80 Years
NCT00590434
Novel Imaging Techniques in Barrett's Esophagus
NCT00576498
Demographics and Findings of Upper Endoscopy Patients
NCT00576992
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Therapeutic Areas
What is open in the Midwest Biomedical Research Foundation pipeline
2 recruiting of 13 indexed (15% open); 6 completed (46%).
Phase mix: 0 late (III/IV) vs 1 early (I/II) (early-phase heavy).
Top condition: Barrett's Esophagus (2 trials), 5 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Midwest Biomedical Research Foundation: open-pipeline peers nationwide
Peers matched on 13 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Midwest Biomedical Research Foundation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 13 trials (± recruiting share)
- Adaptimmune · 13 trials · 0% recruiting
- Agennix · 13 trials · 0% recruiting
- Akili Interactive Labs · 13 trials · 0% recruiting
- Alumis · 13 trials · 8% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this Midwest Biomedical Research Foundation page
13 registered trials is a research-attention snapshot, not an endorsement of Midwest Biomedical Research Foundation or any single study.
- 2 of Midwest Biomedical Research Foundation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Barrett's Esophagus is the condition Midwest Biomedical Research Foundation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Barrett's Esophagus trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Midwest Biomedical Research Foundation pipeline card: 13 registered trials from official public datasets.Report a data error.